Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Apoptosis represents a key anti-cancer therapeutic effector mechanism. During apoptosis, mitochondrial outer membrane permeabilization (MOMP) typically kills cells even in the absence of caspase activity. Caspase activity can also have a variety of unwanted consequences that include DNA damage. We therefore investigated whether MOMP-induced caspase-independent cell death (CICD) might be a better way to kill cancer cells. We find that cells undergoing CICD display potent pro-inflammatory effects relative to apoptosis. Underlying this, MOMP was found to stimulate NF-κB activity through the downregulation of inhibitor of apoptosis proteins. Strikingly, engagement of CICD displays potent anti-tumorigenic effects, often promoting complete tumour regression in a manner dependent on intact immunity. Our data demonstrate that by activating NF-κB, MOMP can exert additional signalling functions besides triggering cell death. Moreover, they support a rationale for engaging caspase-independent cell death in cell-killing anti-cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In vivo , this has been associated with increased tumor infiltration by MHC class II-expressing tumoricidal macrophages and CTLs (Giampazolias et al., 2017; Saito et al., 2019).”
From Immunomodulation by targeted anticancer agents (2021) · cites this paper as Giampazolias et al., 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Mitochondria and cell death: outer membrane permeabilization and beyond
Tait, S. W. G., & Green, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2952 · Cited by 2,593
Self-citationSuppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Hayden, M. S., & Ghosh, S. (2012) · Genes & Development · doi:10.1101/gad.183434.111 · Cited by 1,693
IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis
Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.030 · Cited by 1,218
IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis
Vince, J. E., Wong, W. W.-L., Khan, N., Feltham, R., Chau, D., Ahmed, A. U., Benetatos, C. A., Chunduru, S. K., Condon, S. M., McKinlay, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.037 · Cited by 1,053
Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
White, M. J., McArthur, K., Metcalf, D., Lane, R. M., Cambier, J. C., Herold, M. J., van Delft, M. F., Bedoui, S., Lessene, G., Ritchie, M. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.036 · Cited by 983
Apoptotic Caspases Prevent the Induction of Type I Interferons by Mitochondrial DNA
Rongvaux, A., Jackson, R., Harman, C. C. D., Li, T., West, A. P., de Zoete, M. R., Wu, Y., Yordy, B., Lakhani, S. A., Kuan, C.-Y., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.037 · Cited by 847
Mitochondrial apoptosis: killing cancer using the enemy within
Lopez, J., & Tait, S. W. G. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.85 · Cited by 784
Self-citationRIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8 + T cells
Yatim, N., Jusforgues-Saklani, H., Orozco, S., Schulz, O., Barreira da Silva, R., Reis e Sousa, C., Green, D. R., Oberst, A., & Albert, M. L. (2015) · Science · doi:10.1126/science.aad0395 · Cited by 622
Self-citationProgrammed necrosis in inflammation: Toward identification of the effector molecules
Wallach, D., Kang, T.-B., Dillon, C. P., & Green, D. R. (2016) · Science · doi:10.1126/science.aaf2154 · Cited by 544
TCPA: a resource for cancer functional proteomics data
Li, J., Lu, Y., Akbani, R., Ju, Z., Roebuck, P. L., Liu, W., Yang, J.-Y., Broom, B. M., Verhaak, R. G. W., Kane, D. W., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2650 · Cited by 512
Koo, G.-B., Morgan, M. J., Lee, D.-G., Kim, W.-J., Yoon, J.-H., Koo, J. S., Kim, S. I., Kim, S. J., Son, M. K., Hong, S. S., et al. (2015) · Cell Research · doi:10.1038/cr.2015.56 · Cited by 491
Ichim, G., Lopez, J., Ahmed, S. U., Muthalagu, N., Giampazolias, E., Delgado, M. E., Haller, M., Riley, J. S., Mason, S. M., Athineos, D., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.018 · Cited by 479
Self-citationA fate worse than death: apoptosis as an oncogenic process
Ichim, G., & Tait, S. W. G. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.58 · Cited by 451
Self-citationVaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
Aaes, T. L., Kaczmarek, A., Delvaeye, T., De Craene, B., De Koker, S., Heyndrickx, L., Delrue, I., Taminau, J., Wiernicki, B., De Groote, P., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.037 · Cited by 443
Dondelinger, Y., Jouan-Lanhouet, S., Divert, T., Theatre, E., Bertin, J., Gough, P. J., Giansanti, P., Heck, A. J. R., Dejardin, E., Vandenabeele, P., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.032 · Cited by 431
Martins, L. M., Morrison, A., Klupsch, K., Fedele, V., Moisoi, N., Teismann, P., Abuin, A., Grau, E., Geppert, M., Livi, G. P., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.9848-9862.2004 · Cited by 394
Die another way – non-apoptotic mechanisms of cell death
Tait, S. W. G., Ichim, G., & Green, D. R. (2014) · Journal of Cell Science · doi:10.1242/jcs.093575 · Cited by 366
Self-citationWidespread Mitochondrial Depletion via Mitophagy Does Not Compromise Necroptosis
Tait, S. W. G., Oberst, A., Quarato, G., Milasta, S., Haller, M., Wang, R., Karvela, M., Ichim, G., Yatim, N., Albert, M. L., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.034 · Cited by 303
Self-citationLabi, V, & Erlacher, M. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.20 · Cited by 295
Classical and/or alternative NF-κB pathway activation in multiple myeloma
Demchenko, Y. N., Glebov, O. K., Zingone, A., Keats, J. J., Bergsagel, P. L., & Kuehl, W. M. (2010) · Blood · doi:10.1182/blood-2009-09-243535 · Cited by 288
Caspase-3 Promotes Genetic Instability and Carcinogenesis
Liu, X., He, Y., Li, F., Huang, Q., Kato, T. A., Hall, R. P., & Li, C.-Y. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.03.003 · Cited by 263
HOIP Deficiency Causes Embryonic Lethality by Aberrant TNFR1-Mediated Endothelial Cell Death
Peltzer, N., Rieser, E., Taraborrelli, L., Draber, P., Darding, M., Pernaute, B., Shimizu, Y., Sarr, A., Draberova, H., Montinaro, A., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.066 · Cited by 257
Self-citationRamakrishnan, P., Wang, W., & Wallach, D. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.009 · Cited by 232
A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo
Abulwerdi, F., Liao, C., Liu, M., Azmi, A. S., Aboukameel, A., Mady, A. S. A., Gulappa, T., Cierpicki, T., Owens, S., Zhang, T., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0767 · Cited by 187
Control of canonical NF-κB activation through the NIK–IKK complex pathway
Zarnegar, B., Yamazaki, S., He, J. Q., & Cheng, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707959105 · Cited by 183
Werner, A. B., de Vries, E., Tait, S. W. G., Bontjer, I., & Borst, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201469200 · Cited by 157
Self-citationSilke, J., Hawkins, C. J., Ekert, P. G., Chew, J., Day, C. L., Pakusch, M., Verhagen, A. M., & Vaux, D. L. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108085 · Cited by 133
Lartigue, L., Kushnareva, Y., Seong, Y., Lin, H., Faustin, B., & Newmeyer, D. D. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-07-0649 · Cited by 132
Substrates of IAP Ubiquitin Ligases Identified with a Designed Orthogonal E3 Ligase, the NEDDylator
Zhuang, M., Guan, S., Wang, H., Burlingame, A. L., & Wells, J. A. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.022 · Cited by 125
Verhagen, A. M. W., Kratina, T., Hawkins, C. J., Silke, J., Ekert, P. G., & Vaux, D. L. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402001 · Cited by 112
TRAIL treatment provokes mutations in surviving cells
Lovric, M. M., & Hawkins, C. J. (2010) · Oncogene · doi:10.1038/onc.2010.242 · Cited by 96
Werthmöller, N., Frey, B., Wunderlich, R., Fietkau, R., & Gaipl, U. S. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.129 · Cited by 87
Mito-priming as a method to engineer Bcl-2 addiction
Lopez, J., Bessou, M., Riley, J. S., Giampazolias, E., Todt, F., Rochegüe, T., Oberst, A., Green, D. R., Edlich, F., Ichim, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms10538 · Cited by 62
Self-citationKim, K. W., Moretti, L., & Lu, B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002275 · Cited by 51
Involvement of RNA Polymerase III in Immune Responses
Graczyk, D., White, R. J., & Ryan, K. M. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00990-14 · Cited by 50
Self-citationLecis, D., Mastrangelo, E., Belvisi, L., Bolognesi, M., Civera, M., Cossu, F., Cesare, M. D., Delia, D., Drago, C., Manenti, G., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.09.041 · Cited by 35
Self-citationSMG1 and NIK regulate apoptosis induced by Smac mimetic compounds
Cheung, H. H., Jean, M. S., Beug, S. T., Mrad, R. L., LaCasse, E. C., Baird, S. D., Stojdl, D. F., Screaton, R. A., & Korneluk, R. G. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.25 · Cited by 34
Kim, K. W., Kim, B. J., Chung, C., Jo, D., Kim, I., Song, Y., Kwon, Y., Woo, H., & Jung, Y. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10139 · Cited by 25
Research works printed but not linked: 1
- Li J TCPA: a resource for cancer functional proteomics data Nat Methods 2013 10 1046 1047 PMC4076789 24037243
Cited by
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679
Targeting apoptosis in cancer therapy
Carneiro, B. A., & El-Deiry, W. S. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0341-y · Cited by 2,542
Mitochondria as multifaceted regulators of cell death
Bock, F. J., & Tait, S. W. G. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0173-8 · Cited by 2,450
Self-citationMitochondrial control of inflammation
Marchi, S., Guilbaud, E., Tait, S. W. G., Yamazaki, T., & Galluzzi, L. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00760-x · Cited by 1,027
Self-citation
Metadata
- Authors
- Giampazolias, E., Zunino, B., Dhayade, S., Bock, F., Cloix, C., Cao, K., Roca, A., Lopez, J., Ichim, G., Proïcs, E., Rubio-Patiño, C., Fort, L., Yatim, N., Woodham, E., Orozco, S., Taraborrelli, L., Peltzer, N., Lecis, D., Machesky, L., Walczak, H., Albert, M. L., Milling, S., Oberst, A., Ricci, J.-E., Ryan, K. M., Blyth, K., & Tait, S. W. G.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Inserm (FR)
- Institut Pasteur (FR)
- University of Washington (US)
- University College London (GB)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- University of Glasgow (GB)
- Corresponding author
- Tait, Stephen W. G.
- ORCID
- Giampazolias, Evangelos
- Dhayade, Sandeep
- Bock, Florian
- Cloix, Catherine
- Cao, Kai
- Lopez, Jonathan
- Ichim, Gabriel
- Yatim, Nader
- Woodham, Emma
- Orozco, Susana
- Peltzer, Nieves
- Lecis, Daniele
- Machesky, Laura
- Walczak, Henning
- Albert, Matthew L.
- Milling, Simon
- Oberst, Andrew
- Ricci, Jean-Ehrland
- Ryan, Kevin M.
- Blyth, Karen
- Tait, Stephen W. G.
- Venue
- Nature Cell Biology
- Published
- 2017-08-28
- Volume
- 19
- Issue
- 9
- Pages
- 1116-1129
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC5624512
- OpenAlex
- W2747941681
- Cited by
- 258
- References
- 43
- Citations by year
- 2026: 14 · 2025: 33 · 2024: 29 · 2023: 38 · 2022: 33 · 2021: 26 · 2020: 30 · 2019: 21 · 2018: 27 · 2017: 7
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Update notices
- addendum (2018-02-19)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Funders
- Cancer Research UK (24452, 20145, 22903, 15673, 22311, A20145, 15816)
- Agence Nationale de la Recherche (ANR-11-LABX-0028)
- Medical Research Council (MR/N023625/1)
- National Institute of Allergy and Infectious Diseases (R01AI108685, T32AI106677)
- National Institute of Neurological Disorders and Stroke (R21NS101542)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- mitochondrial outer membrane permeabilization, caspase-independent cell death, NF-κB activation, inhibitor of apoptosis proteins, antitumor immunity, tumor regression, apoptosis, inflammation, cancer therapy
- MeSH terms
- NF-kappaB-Inducing Kinase, Aniline Compounds, Animals, Antineoplastic Agents, Colonic Neoplasms, Genotype, HeLa Cells, Humans, Macrophage Activation, Mice, Inbred BALB C, Mitochondria, Necrosis, Permeability, Phenotype, Sulfonamides, Time Factors, Transfection, Tumor Necrosis Factor-alpha, Signal Transduction, NF-kappa B, Mice, SCID, Mice, Inbred NOD, Apoptosis, Protein Serine-Threonine Kinases, Mice, Knockout, Inflammation Mediators, Caspases, RNA Interference, Receptors, Tumor Necrosis Factor, Type I, Inhibitor of Apoptosis Proteins, Mitochondrial Membranes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.